These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6764116)

  • 1. [Follow-up study of preoperative oral administration of an antineoplastic agent as an adjuvant chemotherapy in stomach cancer].
    Nishioka B; Ouchi T; Watanabe S; Umehara M; Yamane E; Yahata K; Muto F; Kojima O; Nomiyama S; Sakita M; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1427-32. PubMed ID: 6764116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [End result of preoperative adjuvant chemotherapy with oral 5-FU dry syrup in gastric cancer].
    Miyamoto Y; Izuo M; Takeshita M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1929-33. PubMed ID: 3382242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative cancer chemotherapy for gastric cancer].
    Fujimoto S; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Kurihara M; Ohta M; Udagawa I
    Gan To Kagaku Ryoho; 1985 May; 12(5):1010-8. PubMed ID: 3922306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preoperative administration of 5-FU emulsion for lymph nodes metastasis of pancreatic carcinoma].
    Kakizaki K; Yamada Y; Yamauchi H
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1679-81. PubMed ID: 1530330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer--a pilot study using 5-FU tablets compared with surgical operation alone].
    Fujii M; Sakabe T; Wakabayashi K; Kochi M; Mochizuki F; Kasakura Y; Yamagata M; Noro M; Osawa T; Iwai S
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1199-208. PubMed ID: 8031162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative treatment with 5-fluorouracil (5-FU) in gastric and colorectal cancer].
    Kawaura Y; Ohmura K; Hashizume Y; Takayama K; Sakatoku M; Hirano M; Yamada T; Iwa T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):348-52. PubMed ID: 3970555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative adjuvant chemotherapy using NCS (neocarzinostatin) and 5-FU in the treatment of gastric cancer. First report--A comparison with the 5-year survival rate of patients undergoing combined therapy with MMC and 5-FU].
    Yokomori T; Taniguchi T; Iesato H; Sakata Y; Watanabe T; Kawabe K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3064-70. PubMed ID: 2960267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
    Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
    Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative adjuvant chemotherapy with oral anticancer agents for stomach cancer].
    Honda I; Watanabe S; Fujita Y
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1109-17. PubMed ID: 9239164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of pre- and post-operative chemotherapy with oral 5-FU in patients with gastric cancer. Study Group of Pre- and Post-Operative Oral 5-FU in Gastric Cancer].
    Ohmori Y; Kajitani T; Akiyama H; Abe O; Kusama S; Sakakibara N; Sakabe T; Sugano H; Nakajima T; Miwa K
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1781-9. PubMed ID: 8379670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of postoperative longterm chemotherapy against gastric cancer].
    Inokuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):320-5. PubMed ID: 6349534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration and dosage of fluorouracil (5-FU) continuous i.v. infusion in patients with non-curative resected/non-resected gastric cancer].
    Yamaguchi A; Isogai M; Hori A; Kawai M; Yamaguchi R; Kubota T; Yamada T; Maeda A
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):567-72. PubMed ID: 8678514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.